There are 2934 resources available
Has molecular classification changed the medical approach in endometrial cancer?
Presenter: Carien Creutzberg
Session: Treating endometrial cancer in the molecular age
Resources:
Slides
Webcast
Endometrial cancer enters the immunotherapy era
Presenter: Mansoor Raza Mirza
Session: Treating endometrial cancer in the molecular age
Resources:
Slides
Webcast
5478 - Analysis of circulating tumor DNA (ctDNA) from patients enrolled in the IDEA-FRANCE phase III trial: prognostic and predictive value for adjuvant treatment duration
Presenter: Julien Taieb
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
Proffered Paper 1 – Gastrointestinal tumours, colorectal - Invited Discussant 523O and LBA31
Presenter: Claus-Henning Koehne
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Slides
Webcast
2483 - Primary Efficacy analysis results from the SORCE trial (RE05): Adjuvant sorafenib for renal cell carcinoma at intermediate or high risk of relapse: an international, randomised double-blind phase III trial led by the MRC CTU at UCL
Presenter: Tim Eisen
Session: Proffered Paper 2 – Genitourinary tumours, non-prostate
Resources:
Abstract
Slides
Webcast
Proffered Paper 2 – Genitourinary tumours, non-prostate - Invited Discussant 903O
Presenter: Jan Oldenburg
Session: Proffered Paper 2 – Genitourinary tumours, non-prostate
Resources:
Slides
Webcast
4267 - Bevacizumab for children with relapsed & refractory high risk neuroblastoma (RR-HRNB). Results of the BEACON-Neuroblastoma randomized phase 2 trial, a European ITCC-SIOPEN trial
Presenter: Lucas Moreno
Session: Proffered Paper – Haematological malignancies & pediatric oncology
Resources:
Abstract
Slides
Webcast
Triple negative breast cancer (TNBC)
Presenter: Giuseppe Curigliano
Session: Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond
Resources:
Slides
Webcast
DNA repair strategies: Beyond PARP inhibition
Presenter: Andrew Tutt
Session: Novel therapeutic strategies in ABC: Immunotherapy, Antibody Drug Conjugates (ADCs) and beyond
Resources:
Slides
Webcast
Optimal combination for firstline NSCLC
Presenter: Martin Reck
Session: Optimal delivery of immuno-oncology (I-O) in advanced NSCLC
Resources:
Slides
Webcast